Cite
MLA Citation
Amy Flaxman et al.. “Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002).” Lancet, vol. 398, no. 10304, 2021, pp. 981–990. http://access.bl.uk/ark:/81055/vdc_100144485064.0x000052